Fabino Life Sciences IPO is all set to make its debut on 31th Dec with 3.24 cr and is engaged in the manufacturing, marketing, trading, and packing of pharmaceutical and other wellness-focused consumer products.
Fabino life sciences IPO – overview
| IPO Dates | Dec 31, 2021, to Jan 5, 2022 |
| IPO Price | INR 36 per share |
| Fresh issue | 900,000 shares (INR 3.24 crore) |
| Offer For Sale | Nil |
| Total IPO size | 900,000 shares (INR 3.24 crore) |
| Minimum bid (lot size) | 3000 shares |
| Face Value | INR 10 per share |
| Retail Allocation | 50% |
| Listing On | BSE Emerge |
Fabino life sciences IPO – Tentative Dates
| IPO Offer Opening Date | 31 Dec 2021 |
| IPO Closing Date | 05 Jan 2022 |
| Finalization of Basis of Allotment | 10 Jan 2022 |
| Initiation of refunds | 11 Jan 2022 |
| Transfer of shares to demat accounts | 12 Jan 2022 |
| IPO Listing Date | 13 Jan 2022 |
| Opening Price on BSE SME | Coming soon |
| Closing Price on BSE SME | Coming soon |
Company Overview
Fabino Life Sciences is engaged in the manufacturing, marketing, trading, and packing of pharmaceutical and other wellness-focused consumer products. The company’s core business is the marketing of pharmaceutical formulation & products in the domestic market through their own distribution network and sales force under their brand name, getting ayurvedic formulations manufactured through loan licensing facilities, packing, labeling, etc. The company export wellness and FMCG products like coffee, malt powder, protein powder, hair shampoo marketed by them.
Currently, the company has over 70 launched and active products available in markets categorized into (i) Allopathic, (ii) Covid 19, (iii) Food & Wellness, (iv) Herbal, (v) Veterinary, (vi) multi-Vitamin, segments.
The company has its manufacturing unit in the National Capital Region, India.
Industry Overview
The Industry emphasizes developing high-quality and affordable products for all sections of society by harnessing the skills of our competent manpower and other resources. We aim to provide the best quality products at affordable rates for good health and well-being for all. Fabino Life sciences Ltd is engaged in manufacturing, marketing, trading, and packing of pharmaceuticals and other wellness-focused consumer products, our core business is the marketing of pharmaceutical formulations & products in the Domestic market through our distribution network and Salesforce under our brand name, getting our Ayurvedic formulations manufactured through Loan Licensing facilities, Packing, Labeling, etc. We export wellness and FMCG products like Coffee, Malt powder, Protein powder, and Hair shampoo which are marketed by our company.
Strengths:
- An experienced promoter from the pharmaceutical industry
- Diverse product portfolio
- Low debt balance sheet
- Strong marketing and distribution network
Objectives of the issue
- Part repayment of loans
- Funding working capital requirements
- General corporate purposes
Company Financials
| Particulars | 31-Mar-21 | 31-Mar-20 | 31-Mar-19 |
| Total Assets | 22.51 | 35.88 | 85.53 |
| Total Revenue | 30.59 | 75.16 | 27.61 |
| Profit After Tax | 0.30 | 0.68 | 0.001 |
Company Contact Information
Fabino Life Sciences Limited
105, 1st Floor, Barodia Tower, Plot No 12,
D Block Central Market Prashant Vihar,
New Delhi 110085
Phone: +91-9883900021
Email: info@fabinolife.com
Website: https://www.fabinolife.com/
Registrar
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://www.bigshareonline.com/
Lead Manager(s)
- Aryaman Financial Services limited (Past IPO Performance)
Lead Manager Reports
- IPO Lead Manager Performance Summary
- IPO Lead Manager Performance Tracker
